Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | PGK1 | P00558 | 1/20 | 0.42 |
| ▸ | PGK2 | P07205 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NQO1 | P15559 | 1/20 | 0.35 |
| ▸ | POR | P16435 | 1/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20231823 | 0.90 | PGK1 (0.50) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL5830801 | 0.88 | NOS3 (0.44) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL9770020 | 0.87 | GRIN2D (0.43) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL13879978 | 0.80 | NOS3 (0.45) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL394845 | 0.79 | PGK1 (0.41) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL12700588 | 0.78 | NOS3 (0.39) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL5013657 | 0.78 | NOS3 (0.43) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL5014656 | 0.78 | NOS3 (0.39) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL17244913 | 0.78 | ALDH1A1 (0.39) | NOS3NOS1NOS2PGK1PGK2 | |
| SCHEMBL13180246 | 0.78 | CD44 (0.42) | NOS3NOS1NOS2NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108949262-A | A kind of diesel energy-saving power type detersive and preparation method thereof | 滨州仁泰化工有限公司 | 2018-12-07 | — | — | CN | claimed |
| US-9568821-B2 | Patterning process | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-14 | — | — | US | claimed |
| US-9507262-B2 | Resist top-coat composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-11-29 | — | — | US | claimed |
| US-20150234278-A1 | PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-08-20 | — | — | US | claimed |
| US-20150234274-A1 | RESIST TOP-COAT COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-08-20 | — | — | US | claimed |
| US-6451937-B1 | BY THERMALLY REACTING A FUNCTIONALIZING REAGENT AND THE HYDROCARBON IN THE PRESENCE OF A TRANSITION METAL COORDINATION CATALYST | SHELL OIL COMPANY | 2002-09-17 | — | — | US | claimed |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | SHELL OIL COMPANY | 2001-11-08 | — | — | US | claimed |
| US-6084109-A | GAS PHASE OXIDATION AND DEHYDRATION OF A 1,2,4,5-TETRAALKYL-BENZENE UNDER NORMAL PRESSURE AND HEATING USING A DURABLE, THERMOCONDUCTIVE CATALYST SYSTEM OF A CATALYST SUPPORT OF TUNGSTEN AND/OR SILICON CARBIDE | CHINESE PETROLEUM CORP. (TW) | 2000-07-04 | — | — | US | claimed |
| US-12590219-B2 | Phenol compound, conductive paste composition, method for producing conductive paste composition, conductive wire, and method for producing conductive wire | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| EP-4654222-A1 | DEEP EUTECTIC LIQUID, BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR PRODUCING BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-20250353969-A1 | Deep Eutectic Liquid, Bio-Electrode Composition, Bio-Electrode, And Method For Producing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250352110-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR PRODUCING BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-20 | — | — | US | disclosed |
| EP-4651157-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR PRODUCING BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-20030176319-A1 | For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts | GILEAD PHARMASSET LLC | 2003-09-18 | — | — | US | disclosed |
| US-20030162992-A1 | Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde | PHARMASSET, INC. | 2003-08-28 | — | — | US | disclosed |
| WO-2003063771-A2 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET LTD. (BB) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003051306-A2 | N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| US-6084109-A | GAS PHASE OXIDATION AND DEHYDRATION OF A 1,2,4,5-TETRAALKYL-BENZENE UNDER NORMAL PRESSURE AND HEATING USING A DURABLE, THERMOCONDUCTIVE CATALYST SYSTEM OF A CATALYST SUPPORT OF TUNGSTEN AND/OR SILICON CARBIDE | CHINESE PETROLEUM CORP. (TW) | 2000-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176319-A1 | For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts | ENTPD5, CDA, ADA | NOS3 3411/4885NOS1 3501/4885NOS2 4186/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | NOS3 99/4885NOS1 374/4885NOS2 54/4885 |
| US-20030162992-A1 | Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde | DERA, DPYD, DHPS | NOS3 3808/4885NOS1 3303/4885NOS2 3692/4885 |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | AHR, PAH, HRH3 | NOS3 3294/4885NOS1 3608/4885NOS2 2776/4885 |
| US-12590219-B2 | Phenol compound, conductive paste composition, method for producing conductive paste composition, conductive wire, and method for producing conductive wire | PYCARD, NPR1, TNNC1 | NOS3 545/4885NOS1 207/4885NOS2 641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.